Preventative migraine medication
Pro Research Analysisby 
Searched over 200M research papers
Preventative Migraine Medication: An Overview
Introduction to Preventative Migraine Medication
Preventative migraine medication is essential for individuals who experience frequent or severe migraine attacks. These medications aim to reduce the frequency, severity, and duration of migraines, thereby improving the quality of life for sufferers. Preventative treatments are typically administered daily over extended periods, although they can also be used episodically or subacutely depending on the patient's needs .
Categories of Preventative Medications
High Efficacy Alternatives
Medications with high efficacy for migraine prevention include β-blockers (e.g., propranolol), tricyclic antidepressants (e.g., amitriptyline), and antiepileptic drugs such as divalproex and topiramate Silberstein1997Vikelis2009Silberstein2002. These drugs are often considered first-line treatments due to their proven effectiveness and relatively manageable side effects.
Lower Efficacy Alternatives
Selective serotonin reuptake inhibitors (SSRIs), calcium channel antagonists, and non-steroidal anti-inflammatory drugs (NSAIDs) are also used for migraine prevention but are generally considered to have lower efficacy compared to the first-line options Silberstein1997Silberstein2002. Despite this, they can be beneficial for patients who do not respond well to high-efficacy medications or who experience significant side effects.
Second-Line Choices
Second-line choices include methysergide and monoamine oxidase inhibitors (MAOIs), which are highly effective but often reserved for patients who do not respond to other treatments due to their potential for more severe side effects .
Emerging Treatments
Calcitonin Gene-Related Peptide (CGRP) Antagonists
Recent advancements have introduced CGRP antagonists like atogepant and fremanezumab, which have shown significant promise in reducing migraine days. Atogepant, for instance, demonstrated a reduction in migraine days by 3.7 to 4.2 days per month compared to placebo in a 12-week trial . Similarly, fremanezumab was effective in patients who had not responded to multiple other preventive medications, reducing migraine days significantly compared to placebo .
Galcanezumab
Galcanezumab, another CGRP antagonist, has also been effective in patients who have failed previous preventive treatments. It reduced monthly migraine headache days by an average of 4.1 days compared to 1.0 days with placebo, showing a significant improvement .
Complementary and Alternative Treatments
NSAIDs and Other Supplements
NSAIDs such as ibuprofen and naproxen, along with supplements like magnesium, riboflavin, and Co-Q10, have been found to be effective for some patients. Petasites (butterbur) is particularly noted for its efficacy in reducing migraine frequency and severity . These treatments are often considered when traditional pharmacologic therapies are not suitable or as adjunctive therapies.
Considerations for Choosing Preventative Treatment
The choice of preventative treatment depends on several factors, including the drug's efficacy, side effects, patient preferences, and the presence of comorbid conditions. It is crucial to start with a low dose and give each treatment an adequate trial period. Regular re-evaluation of the therapy is necessary to ensure its continued effectiveness and to adjust the treatment plan as needed Silberstein1997Silberstein2002.
Conclusion
Preventative migraine medications play a crucial role in managing chronic and severe migraine conditions. While traditional medications like β-blockers, tricyclic antidepressants, and antiepileptic drugs remain the cornerstone of treatment, newer options like CGRP antagonists offer promising alternatives for patients who do not respond to conventional therapies. Complementary treatments, including NSAIDs and various supplements, provide additional options for comprehensive migraine management. The choice of treatment should be individualized, taking into account the patient's specific needs, preferences, and medical history.
Sources and full results
Most relevant research papers on this topic